Topical nepafenac inhibits ocular neovascularization.
Takahashi K, Saishin Y, Saishin Y, Mori K, Ando A, Yamamoto S, Oshima Y, Nambu H, Melia MB, Bingaman DP, Campochiaro PA.
Takahashi K, et al. Among authors: oshima y.
Invest Ophthalmol Vis Sci. 2003 Jan;44(1):409-15. doi: 10.1167/iovs.02-0346.
Invest Ophthalmol Vis Sci. 2003.
PMID: 12506103